Werewolf Therapeutics Files 2024 10-K

Ticker: HOWL · Form: 10-K · Filed: Mar 11, 2025 · CIK: 1785530

Werewolf Therapeutics, Inc. 10-K Filing Summary
FieldDetail
CompanyWerewolf Therapeutics, Inc. (HOWL)
Form Type10-K
Filed DateMar 11, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-K, annual-report, pharmaceuticals

TL;DR

Werewolf Therapeutics filed its 2024 10-K, detailing financials and operations for the year ending Dec 31, 2024.

AI Summary

Werewolf Therapeutics, Inc. filed its 2024 10-K on March 11, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, incorporated in Delaware, is based in Watertown, MA, and operates in the pharmaceutical preparations sector. Key financial data and operational details for the fiscal year 2024 are presented in this filing.

Why It Matters

This filing provides investors and stakeholders with a comprehensive overview of Werewolf Therapeutics' financial health and operational status for the past fiscal year, crucial for investment decisions.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Werewolf Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition, which are typically detailed in a 10-K filing.

Key Numbers

  • 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
  • 2025-03-11 — Filing Date (Date the 10-K was submitted to the SEC)

Key Players & Entities

  • Werewolf Therapeutics, Inc. (company) — Filer of the 10-K
  • 200 TALCOTT AVENUE, 2ND FLOOR, WATERTOWN, MA 02472 (location) — Business and mailing address
  • 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
  • DE (state) — State of Incorporation
  • 2024-12-31 (date) — Fiscal Year End
  • 2025-03-11 (date) — Filing Date

FAQ

What is Werewolf Therapeutics, Inc.'s primary business activity?

Werewolf Therapeutics, Inc. operates in the Pharmaceutical Preparations sector, with the Standard Industrial Classification code 2834.

When did Werewolf Therapeutics, Inc. file its 10-K report?

The 10-K report was filed on March 11, 2025.

What fiscal year does this 10-K filing cover?

This 10-K filing covers the fiscal year ending December 31, 2024.

Where is Werewolf Therapeutics, Inc. located?

The company's business and mailing address is 200 Talcott Avenue, 2nd Floor, Watertown, MA 02472.

In which state was Werewolf Therapeutics, Inc. incorporated?

Werewolf Therapeutics, Inc. was incorporated in Delaware (DE).

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on March 11, 2025 regarding Werewolf Therapeutics, Inc. (HOWL).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.